Review of CAH screening programmes and the Scottish experience.
D019326:17-alpha-Hydroxyprogesterone; D000312:Adrenal Hyperplasia, Congenital / Q000097:blood / Q000517:prevention & control*; D003951:Diagnostic Errors; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D007231:Infant, Newborn; D008403:Mass Screening; D012606:Scotland
D006908:Hydroxyprogesterones; D019326:17-alpha-Hydroxyprogesterone